198 related articles for article (PubMed ID: 10556949)
1. Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation.
Al-Ani B; Saifeddine M; Kawabata A; Hollenberg MD
Br J Pharmacol; 1999 Nov; 128(5):1105-13. PubMed ID: 10556949
[TBL] [Abstract][Full Text] [Related]
2. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
[TBL] [Abstract][Full Text] [Related]
3. Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport.
Vergnolle N; Macnaughton WK; Al-Ani B; Saifeddine M; Wallace JL; Hollenberg MD
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7766-71. PubMed ID: 9636225
[TBL] [Abstract][Full Text] [Related]
4. Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands.
Al-Ani B; Saifeddine M; Kawabata A; Renaux B; Mokashi S; Hollenberg MD
J Pharmacol Exp Ther; 1999 Aug; 290(2):753-60. PubMed ID: 10411588
[TBL] [Abstract][Full Text] [Related]
5. Proteinase-activated receptor 2: differential activation of the receptor by tethered ligand and soluble peptide analogs.
Al-Ani B; Wijesuriya SJ; Hollenberg MD
J Pharmacol Exp Ther; 2002 Sep; 302(3):1046-54. PubMed ID: 12183662
[TBL] [Abstract][Full Text] [Related]
6. Derivatized 2-furoyl-LIGRLO-amide, a versatile and selective probe for proteinase-activated receptor 2: binding and visualization.
Hollenberg MD; Renaux B; Hyun E; Houle S; Vergnolle N; Saifeddine M; Ramachandran R
J Pharmacol Exp Ther; 2008 Aug; 326(2):453-62. PubMed ID: 18477767
[TBL] [Abstract][Full Text] [Related]
7. Proteinase-activated receptor-2: key role of amino-terminal dipeptide residues of the tethered ligand for receptor activation.
Al-Ani B; Hansen KK; Hollenberg MD
Mol Pharmacol; 2004 Jan; 65(1):149-56. PubMed ID: 14722246
[TBL] [Abstract][Full Text] [Related]
8. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity.
Roy SS; Saifeddine M; Loutzenhiser R; Triggle CR; Hollenberg MD
Br J Pharmacol; 1998 Apr; 123(7):1434-40. PubMed ID: 9579740
[TBL] [Abstract][Full Text] [Related]
9. Proteinase-activated receptor-2 (PAR2): vascular effects of a PAR2-derived activating peptide via a receptor different than PAR2.
McGuire JJ; Dai J; Andrade-Gordon P; Triggle CR; Hollenberg MD
J Pharmacol Exp Ther; 2002 Dec; 303(3):985-92. PubMed ID: 12438518
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor.
Saifeddine M; Roy SS; Al-Ani B; Triggle CR; Hollenberg MD
Br J Pharmacol; 1998 Dec; 125(7):1445-54. PubMed ID: 9884072
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney.
Gui Y; Loutzenhiser R; Hollenberg MD
Am J Physiol Renal Physiol; 2003 Jul; 285(1):F95-104. PubMed ID: 12644441
[TBL] [Abstract][Full Text] [Related]
12. A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists.
Compton SJ; Cairns JA; Palmer KJ; Al-Ani B; Hollenberg MD; Walls AF
J Biol Chem; 2000 Dec; 275(50):39207-12. PubMed ID: 10995771
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
[TBL] [Abstract][Full Text] [Related]
14. Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2.
Hollenberg MD; Saifeddine M; Al-Ani B; Gui Y
Can J Physiol Pharmacol; 1999 Jun; 77(6):458-64. PubMed ID: 10537233
[TBL] [Abstract][Full Text] [Related]
15. Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.
Huang SC
Regul Pept; 2014 Feb; 189():46-50. PubMed ID: 24631471
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
Huang SC
Regul Pept; 2007 Jul; 142(1-2):37-43. PubMed ID: 17335921
[TBL] [Abstract][Full Text] [Related]
17. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue.
Saifeddine M; al-Ani B; Cheng CH; Wang L; Hollenberg MD
Br J Pharmacol; 1996 Jun; 118(3):521-30. PubMed ID: 8762073
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands.
Kawabata A; Saifeddine M; Al-Ani B; Leblond L; Hollenberg MD
J Pharmacol Exp Ther; 1999 Jan; 288(1):358-70. PubMed ID: 9862790
[TBL] [Abstract][Full Text] [Related]
19. Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells.
Nakayama T; Hirano K; Shintani Y; Nishimura J; Nakatsuka A; Kuga H; Takahashi S; Kanaide H
Br J Pharmacol; 2003 Jan; 138(1):121-30. PubMed ID: 12522081
[TBL] [Abstract][Full Text] [Related]
20. Selective tryptic cleavage at the tethered ligand site of the amino terminal domain of proteinase-activated receptor-2 in intact cells.
Al-Ani B; Hollenberg MD
J Pharmacol Exp Ther; 2003 Mar; 304(3):1120-8. PubMed ID: 12604689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
